Altitude Investment Management
VC Fund
New York, United States
Altitude Investment Management is a VC fund in New York focused on Cannabis and Agriculture. Altitude is a New York-based venture capital fund manager focused on the global cannabis industry. The manager's strategy is to invest in a range of early to growth stage companies in North America and Europe that support this rapidly growing industry. Our principals have spent their careers launching and managing alternative investmentfunds, including distressed debt and leveraged credit strategies. We have been involved in highly-regulated industries for decades, and this experience makes our leadership team uniquely qualified to face the regulatory and funding challenges within the cannabis industry.Having invested in the cannabis industry for more than three years, Altitude has deep relationships with legal and regulatory professionals, CEOs of cannabis companies, industry organizations, and consultants.
- Total investments:
- 10
- Last investment:
- Lead investor:
- 40%
- Fund size:
- $8.5M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Altitude Investment Management invests in
Stages Altitude Investment Management invests in
Countries Altitude Investment Management invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series A
- $3.4M–$17M
- Series B
- $7.5M–$7.5M
- Series C
- $7M–$28M
Investment Focus
Industry
- Cannabis 5 (50%)
- Agriculture 2 (20%)
- Health Care 2 (20%)
- Biotechnology 2 (20%)
- Market Research 2 (20%)
Stage
- Series A 4 (40%)
- Series C 2 (20%)
- Series B 1 (10%)
- Venture - Series Unknown 1 (10%)
Country
- United States 6 (60%)
- Switzerland 1 (10%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Jon Trauben
Partner & Co-founder
|
Partner & Co-founder | Total investments: 2 | Find email | |
Christian Mark
Director of Marketing & Investor Relations
|
Director of Marketing & Investor Relations | Total investments: 0 | Find email | |
John Brecker
Partner
|
Partner | Total investments: 0 | Find email | |
Michael Goldberg
Partner
|
Partner | Total investments: 0 | Find email | |
Roderick Stephan
Partner
|
Partner | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| PathogenDx has developed a microarray based test specifically designed for the cannabis, botanical, food and agricultural testing markets. Our technology allows test labs to conduct between 12- 48 tests in parallel, testing up to 20 pathogens per test in less than a days’ shift. This is done at a fraction of the cost of plate counts or RealtimePCR. Our Raw Sample technology allows laboratories to bypass almost 20 steps that Real-time PCR must perform for DNA extraction and purification. PathogenDx technology bypasses the need for purification, quantitation, and normalization increasing the speed and affordability of pathogen screening. This helps our customers reduce testing time by 12 hours on the front end, and avoid spending money on sample prep kits and additional instrumentation. | $7.5M / Series B / Sep 30, 2019 | ||
| KannaSwiss creates natural CBD solutions designed to relieve pain, increase health, and support a more sustainable level of happiness. | $5.5M / Venture - Series Unknown / Sep 23, 2019 | ||
| Canndescent is a state compliant cultivator of premium cannabis. Canndescent's services include a combination of quality management and deep cultivation expertise and abandons traditional strain names, allowing customers to get cannabis flower produced, packaged, and distributed in accordance with all state and local laws. | $27.5M / Series C / Sep 10, 2019 | ||
| BDSA they provides retailers, manufacturers, brands, wholesalers, and investors with actionable insights to drive profitability, increase revenues, and improve stockholdings. | $7M / Series C / Aug 20, 2019 | ||
| Wurk is the leader in HR, Payroll, and Payment technology servicing the fastest-growing emerging industry, cannabis! Wurk's proprietary Compliant Payment Cloud underwriters cannabis businesses enabling them to process payments for payroll, taxes, 401k, benefits, and more positioning Wurk as the largest payments processor in the industry. TheirSaaS HCM Cloud provides Modern HR, Payroll, Time & Attendance, Scheduling accessible on any device, including tablets and mobile. Wurk's Intralytics Cloud (integration meets analytics) connects the industries leading technology providers allowing operators to combine and analyze data to inform mission-critical decisions. Wurk is also assembling this data to provide industry benchmarks to help operators compare their KPIs to the trends of the industry. Wurk's unique platform is proving that Human Capital Management, Workforce Management, and Payment technology providers can add significant value to their customers by focusing on their vertical-specific needs.Wurk was founded in August 2015 by Keegan Peterson. And it is headquartered in Denver, Colorado. | $17M / Series A / Feb 12, 2019 | ||
| Springbig provides loyalty, digital communications, and CRM technology solutions to retailers in the cannabis industry. It was founded in 2012 and is headquartered in Boca Raton, Florida. After years of experience in big-box retail, their founders saw tremendous opportunity in the underserved cannabis industry and decided to bring advanced loyaltyprograms, an essential marketing tool in such a competitive industry, to cannabis dispensaries and brands. | $5M / Series A / Dec 06, 2018 | ||
| Front Range Biosciences brings modern agriculture to cannabis and hemp to improve reliability, efficiency, and safety for cultivators and consumers. They provide advanced agricultural science services to plant growers. | $10M / Series A / Oct 04, 2018 | ||
| Canndescent is a state compliant cultivator of premium cannabis. Canndescent's services include a combination of quality management and deep cultivation expertise and abandons traditional strain names, allowing customers to get cannabis flower produced, packaged, and distributed in accordance with all state and local laws. | $13M / Series C / Sep 07, 2018 | ||
| PathogenDx has developed a microarray based test specifically designed for the cannabis, botanical, food and agricultural testing markets. Our technology allows test labs to conduct between 12- 48 tests in parallel, testing up to 20 pathogens per test in less than a days’ shift. This is done at a fraction of the cost of plate counts or RealtimePCR. Our Raw Sample technology allows laboratories to bypass almost 20 steps that Real-time PCR must perform for DNA extraction and purification. PathogenDx technology bypasses the need for purification, quantitation, and normalization increasing the speed and affordability of pathogen screening. This helps our customers reduce testing time by 12 hours on the front end, and avoid spending money on sample prep kits and additional instrumentation. | $3.4M / Series A / Jul 17, 2018 | ||
| See all 10 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Altitude Investment Management invest in?
Altitude Investment Management invests primarily in Cannabis, Agriculture and Health Care startups, most often at Series A and Series C stage. Most of the 10 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Altitude Investment Management's check size?
Altitude Investment Management typically joins rounds of $3.4M–$17M at Series A, $7.5M–$7.5M at Series B and $7M–$28M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Altitude Investment Management participates in.
How do I contact Altitude Investment Management?
Public channels for Altitude Investment Management include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Altitude Investment Management?
The team at Altitude Investment Management includes Jon Trauben (Partner & Co-founder), Christian Mark (Director of Marketing & Investor Relations) and John Brecker (Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
